Literature DB >> 24097993

Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes.

L A González1, S M A Toloza, G McGwin, G S Alarcón.   

Abstract

Ethnicity is a biological and a social construct which encompasses ancestral genes, cultural, geographic and socioeconomic characteristics shared within a population. It is clear that no homogeneous racial groups exist within the human race as demonstrated when examining ancestry informative markers. Both the genetic and non-genetic components of ethnicity exert influence in the expression and outcome of systemic lupus erythematosus (SLE), including disease activity, damage accrual, work disability and mortality. Although it is difficult to determine the extent to which the differences observed in these parameters are caused by genetic or non-genetic factors, early in the disease genetic factors seem to play a more important role as determinants of the differences observed between SLE patients from various ethnic groups. Over the course of the disease, non-genetic factors seem to play a more important role. By and large, SLE is more frequent and more severe with higher disease activity and more damage accrual in non-Caucasian populations (Hispanics, African descendants and Asians) than in Caucasians. To overcome these differences it is necessary to optimize health care access to disadvantaged populations and use innovative tools to increase disease awareness and improve treatment adherence.

Entities:  

Keywords:  Systemic lupus erythematosus; ethnicity; outcome

Mesh:

Year:  2013        PMID: 24097993     DOI: 10.1177/0961203313502571

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  35 in total

1.  Associations of osteoprotegerin with coronary artery calcification among women with systemic lupus erythematosus and healthy controls.

Authors:  I G Poornima; K Shields; L H Kuller; S M Manzi; R Ramsey-Goldman; C Richardson; E Rhew; D D Dunlop; J Song; D Edmundowicz; G T Kondos; J J Carr; C B Langman; H Price; A H Chung; L B Santelices; R H Mackey
Journal:  Lupus       Date:  2018-01-01       Impact factor: 2.911

2.  Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.

Authors: 
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

Review 3.  Lupus Nephritis: A Different Disease in European Patients?

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Kidney Dis (Basel)       Date:  2015-08-28

Review 4.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

5.  Pathways of impending disease flare in African-American systemic lupus erythematosus patients.

Authors:  Melissa E Munroe; Evan S Vista; Joan T Merrill; Joel M Guthridge; Virginia C Roberts; Judith A James
Journal:  J Autoimmun       Date:  2017-02-02       Impact factor: 7.094

6.  Spectrum of systemic lupus erythematosus in Oman: from childhood to adulthood.

Authors:  Asma Al Rasbi; Eiman Abdalla; Rabab Sultan; Nasreen Abdullah; Juma Al Kaabi; Ibrahim Al-Zakwani; Reem Abdwani
Journal:  Rheumatol Int       Date:  2018-05-02       Impact factor: 2.631

7.  B cells from African American lupus patients exhibit an activated phenotype.

Authors:  Laurence C Menard; Sium Habte; Waldemar Gonsiorek; Deborah Lee; Dana Banas; Deborah A Holloway; Nataly Manjarrez-Orduno; Mark Cunningham; Dawn Stetsko; Francesca Casano; Selena Kansal; Patricia M Davis; Julie Carman; Clarence K Zhang; Ferva Abidi; Richard Furie; Steven G Nadler; Suzanne J Suchard
Journal:  JCI Insight       Date:  2016-06-16

Review 8.  Clinical perspectives on lupus genetics: advances and opportunities.

Authors:  Judith A James
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

9.  Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary.

Authors:  Manuel F Ugarte-Gil; Guillermo J Pons-Estel; Julio Molineros; Daniel Wojdyla; Gerald McGwin; Swapan K Nath; Bernardo A Pons-Estel; Marta Alarcón-Riquelme; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2015-09-27       Impact factor: 7.580

10.  Smoking associates with distinct clinical phenotypes in patients with systemic lupus erythematosus: a nationwide Danish cross-sectional study.

Authors:  Henrik Christian Bidstrup Leffers; Anne Troldborg; Anne Voss; Salome Kristensen; Jesper Lindhardsen; Prabhat Kumar; Asta Linauskas; Lars Juul; Niels Steen Krogh; Bent Deleuran; Lene Dreyer; Søren Jacobsen
Journal:  Lupus Sci Med       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.